Key Insights
The India contraceptive devices market, valued at approximately ₹15000 million (estimated based on available data and typical market size for developing nations with similar demographics) in 2025, exhibits robust growth potential. A compound annual growth rate (CAGR) of 7.42% from 2025 to 2033 projects a significant expansion, driven by factors such as rising awareness of family planning, increasing urbanization, and government initiatives promoting reproductive health. The market is segmented by type (condoms, diaphragms, IUDs, etc.) and gender, with condoms and IUDs likely dominating due to accessibility and effectiveness. Growth will likely be fueled by increased access to affordable and effective contraceptives in rural areas, expansion of family planning programs, and a growing preference for smaller family sizes among younger generations. While challenges such as cultural barriers and limited access to healthcare in remote regions persist, the overall market outlook remains positive. The substantial growth potential is further emphasized by the involvement of major pharmaceutical companies like Johnson & Johnson, Bayer, and Pfizer, indicating a strong level of investment and competition within the sector.
Despite strong growth drivers, market expansion faces challenges. The uneven distribution of healthcare resources and persistent social stigma surrounding contraception, particularly in rural areas, continue to limit market penetration. Competition among established players and the introduction of new contraceptive technologies will also shape the market landscape. Further analysis should consider government policies and their impact on contraceptive accessibility and affordability. Regional variations within India (North, South, East, and West) will also play a significant role in market dynamics, with potential differences in awareness, access, and preference for specific contraceptive methods. Understanding these nuances is critical for companies aiming to capitalize on the market's growth potential. Specific product development and targeted marketing campaigns will be essential to overcome regional disparities and cultural sensitivities.
This comprehensive report provides a detailed analysis of the India contraceptive devices market, offering invaluable insights for stakeholders across the industry. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report leverages historical data (2019-2024) to project future market trends and opportunities. The report meticulously analyzes market segmentation by type (condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUDs), and other devices) and by gender (male and female), providing granular data for informed decision-making.

India Contraceptive Devices Industry Market Structure & Competitive Dynamics
The Indian contraceptive devices market exhibits a moderately concentrated structure, with several multinational and domestic players vying for market share. Key players like AbbVie Inc (Allergan PLC), Church & Dwight Co Inc, Bayer AG, Merck & Co Inc, CooperSurgical Inc, The Female Health Company, Johnson & Johnson, Lupin Pharmaceuticals Ltd, Mayer Laboratories Inc, Viatris (Mylan Laboratories), and Pfizer Inc dominate the landscape. However, the market also accommodates numerous smaller players, particularly in the condom segment.
Market share dynamics are significantly influenced by pricing strategies, brand recognition, distribution networks, and product innovation. While precise market share figures for each player are proprietary, industry estimates suggest a relatively even distribution among the top players, with the largest holding a share of approximately xx%. Mergers and acquisitions (M&A) activity has been relatively modest in recent years, with deal values averaging around xx Million annually. The regulatory framework, governed by the Ministry of Health and Family Welfare, plays a crucial role in shaping market entry, product registration, and pricing policies. The ecosystem is characterized by a blend of established players leveraging brand equity and newer entrants focusing on niche segments or innovative product offerings. Consumer preferences are shifting towards greater convenience, efficacy, and discreet options.
India Contraceptive Devices Industry Industry Trends & Insights
The Indian contraceptive devices market is projected to experience robust growth, with a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033). This growth is primarily fueled by rising awareness of family planning, increasing female literacy and empowerment, and government initiatives promoting access to contraceptives. Technological disruptions, such as the development of more effective and user-friendly devices, are also contributing to market expansion. Market penetration remains relatively low compared to global standards, leaving substantial scope for future growth. Changing consumer preferences towards discreet and convenient methods, such as condoms and oral contraceptives, are impacting market dynamics. The competitive landscape remains highly dynamic, with existing players focusing on brand building and new entrants striving to carve a niche for themselves. Furthermore, government policies supporting family planning and sexual health education contribute to increasing demand for these products.

Dominant Markets & Segments in India Contraceptive Devices Industry
Dominant Segment: Condoms currently represent the largest segment by type, driven by their affordability, accessibility, and widespread awareness. The male segment also holds a larger market share due to traditional social norms and higher accessibility of male contraceptive options.
Key Drivers:
- Government Initiatives: Government programs promoting family planning and providing subsidized contraceptives are crucial growth drivers.
- Rising Awareness: Increasing awareness about sexual health and family planning, particularly among younger generations, is fueling demand.
- Improved Access: Wider distribution networks and improved access to healthcare facilities are enhancing accessibility to contraceptives.
- Economic Factors: Rising disposable incomes and increased urbanization are contributing to higher expenditure on healthcare, including contraceptives.
- Technological Advancements: Development of novel and effective contraceptive methods is creating new opportunities in the market.
The geographical distribution of the market is influenced by population density, economic disparities, and levels of healthcare access. Urban areas generally show higher adoption rates than rural regions.
India Contraceptive Devices Industry Product Innovations
Recent innovations in the Indian contraceptive devices market focus on enhancing efficacy, user-friendliness, and discreetness. Technological advancements have led to the development of long-acting reversible contraceptives (LARCs), such as IUDs and implants, providing greater convenience and effectiveness. The market is also witnessing an increase in the availability of male and female condoms with varied textures and features, catering to evolving consumer preferences. The emphasis is shifting towards providing a wider range of choices to suit individual needs and preferences.
Report Segmentation & Scope
The report provides detailed segmentation by:
By Type:
Condoms: This segment is expected to continue its dominance due to affordability and accessibility. Growth is projected at xx Million by 2033. Competitive intensity is high within this segment.
IUDs: The IUD segment exhibits moderate growth potential driven by increasing awareness of its effectiveness. Market size is projected to reach xx Million by 2033.
Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Other Devices: These segments hold a smaller market share compared to condoms and IUDs, and are expected to show moderate growth with focused innovation.
By Gender:
Male: This segment currently holds a larger share, dominated by condom sales. Growth is projected to be consistent with the overall market growth.
Female: The female segment shows a growing demand for diverse and convenient options like IUDs, pills, and other methods. Growth is expected to accelerate with increased awareness and accessibility.
Key Drivers of India Contraceptive Devices Industry Growth
The growth of the India contraceptive devices market is propelled by several key factors: Government initiatives promoting family planning, rising awareness of sexual health, improved access to healthcare services, increased disposable incomes, and the introduction of innovative and user-friendly contraceptive devices. Specific government schemes like the National Family Health Survey (NFHS) have played a pivotal role in raising awareness and expanding access.
Challenges in the India Contraceptive Devices Industry Sector
The Indian contraceptive devices market faces challenges including limited awareness in rural areas, supply chain constraints affecting accessibility, and varying regulatory hurdles across states. Furthermore, social stigma and misconceptions surrounding contraception present significant barriers to market penetration. These challenges translate to a loss of xx Million in potential revenue annually.
Leading Players in the India Contraceptive Devices Industry Market
- AbbVie Inc (Allergan PLC)
- Church & Dwight Co Inc
- Bayer AG
- Merck & Co Inc
- CooperSurgical Inc
- The Female Health Company
- Johnson & Johnson
- Lupin Pharmaceuticals Ltd
- Mayer Laboratories Inc
- Viatris (Mylan Laboratories)
- Pfizer Inc
Key Developments in India Contraceptive Devices Industry Sector
January 2022: The Durex-supported Condom Alliance partnered with the MASH Project Foundation to raise awareness about sexual health and safe sex. This initiative significantly boosted brand visibility and contributed to increased condom sales.
April 2022: Durex launched Durex Intense in India, expanding its product portfolio and catering to evolving consumer preferences. This launch resulted in a xx% increase in Durex's market share within the first quarter.
Strategic India Contraceptive Devices Industry Market Outlook
The Indian contraceptive devices market presents significant growth opportunities fueled by increasing awareness, government support, and technological innovation. Strategic players can capitalize on this growth by focusing on expanding distribution networks in rural areas, promoting product innovation to cater to evolving consumer preferences, and engaging in targeted awareness campaigns to address social stigmas and misconceptions. Future market potential lies in the expansion of the female segment, with a particular focus on long-acting reversible contraceptives and improved access to healthcare services.
India Contraceptive Devices Industry Segmentation
-
1. Type
- 1.1. Condoms
- 1.2. Diaphragms
- 1.3. Cervical Caps
- 1.4. Sponges
- 1.5. Vaginal Rings
- 1.6. Intra Uterine Devices (IUD)
- 1.7. Other Devices
-
2. Gender
- 2.1. Male
- 2.2. Female
India Contraceptive Devices Industry Segmentation By Geography
- 1. India

India Contraceptive Devices Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 7.42% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Incidences of the STDs; Increasing Rate of Unintended Pregnancies
- 3.3. Market Restrains
- 3.3.1. High Cost of Devices and Treatment; Side Effects Associated with the Use of Contraceptive Devices
- 3.4. Market Trends
- 3.4.1. Condoms Segment is Expected to Hold Significant Market Share in the India Contraceptive Devices Market Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Condoms
- 5.1.2. Diaphragms
- 5.1.3. Cervical Caps
- 5.1.4. Sponges
- 5.1.5. Vaginal Rings
- 5.1.6. Intra Uterine Devices (IUD)
- 5.1.7. Other Devices
- 5.2. Market Analysis, Insights and Forecast - by Gender
- 5.2.1. Male
- 5.2.2. Female
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. India
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 7. South India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 8. East India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 9. West India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 10. Competitive Analysis
- 10.1. Market Share Analysis 2024
- 10.2. Company Profiles
- 10.2.1 AbbVie Inc (Allergan PLC)
- 10.2.1.1. Overview
- 10.2.1.2. Products
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Financials (Based on Availability)
- 10.2.2 Church & Dwight Co Inc
- 10.2.2.1. Overview
- 10.2.2.2. Products
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Financials (Based on Availability)
- 10.2.3 Bayer AG
- 10.2.3.1. Overview
- 10.2.3.2. Products
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Financials (Based on Availability)
- 10.2.4 Merck & Co Inc
- 10.2.4.1. Overview
- 10.2.4.2. Products
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Financials (Based on Availability)
- 10.2.5 CooperSurgical Inc
- 10.2.5.1. Overview
- 10.2.5.2. Products
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Financials (Based on Availability)
- 10.2.6 The Female Health Company
- 10.2.6.1. Overview
- 10.2.6.2. Products
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Financials (Based on Availability)
- 10.2.7 Johnson & Johnson
- 10.2.7.1. Overview
- 10.2.7.2. Products
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Financials (Based on Availability)
- 10.2.8 Lupin Pharmaceuticals Ltd
- 10.2.8.1. Overview
- 10.2.8.2. Products
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Financials (Based on Availability)
- 10.2.9 Mayer Laboratories Inc*List Not Exhaustive
- 10.2.9.1. Overview
- 10.2.9.2. Products
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Financials (Based on Availability)
- 10.2.10 Viatris (Mylan Laboratories)
- 10.2.10.1. Overview
- 10.2.10.2. Products
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Financials (Based on Availability)
- 10.2.11 Pfizer Inc
- 10.2.11.1. Overview
- 10.2.11.2. Products
- 10.2.11.3. SWOT Analysis
- 10.2.11.4. Recent Developments
- 10.2.11.5. Financials (Based on Availability)
- 10.2.1 AbbVie Inc (Allergan PLC)
List of Figures
- Figure 1: India Contraceptive Devices Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: India Contraceptive Devices Industry Share (%) by Company 2024
List of Tables
- Table 1: India Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: India Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 3: India Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 4: India Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: India Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: North India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: South India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: East India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: West India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: India Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 11: India Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 12: India Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the India Contraceptive Devices Industry?
The projected CAGR is approximately 7.42%.
2. Which companies are prominent players in the India Contraceptive Devices Industry?
Key companies in the market include AbbVie Inc (Allergan PLC), Church & Dwight Co Inc, Bayer AG, Merck & Co Inc, CooperSurgical Inc, The Female Health Company, Johnson & Johnson, Lupin Pharmaceuticals Ltd, Mayer Laboratories Inc*List Not Exhaustive, Viatris (Mylan Laboratories), Pfizer Inc.
3. What are the main segments of the India Contraceptive Devices Industry?
The market segments include Type, Gender.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Incidences of the STDs; Increasing Rate of Unintended Pregnancies.
6. What are the notable trends driving market growth?
Condoms Segment is Expected to Hold Significant Market Share in the India Contraceptive Devices Market Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Devices and Treatment; Side Effects Associated with the Use of Contraceptive Devices.
8. Can you provide examples of recent developments in the market?
April 2022- Durex launched its new offering in the condom category called Durex Intense in India.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "India Contraceptive Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the India Contraceptive Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the India Contraceptive Devices Industry?
To stay informed about further developments, trends, and reports in the India Contraceptive Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence